A higher frequency of KRAS mutations was observed in tumors from Black patients (Asian, 39%; Black, 53%; White, 44%) driven specifically by a prevalence of KRAS G12D mutations ( Figure 2 ); however, this did not reach statistical significance.
← all excerpts
Colorectal cancers from distinct ancestral populations show variations in BRAF mutation frequency.
1
—
—